Itamar™ Medical and SoClean® Announce Collaboration to Offer WatchPAT™ ONE and Other Digital Health Services Through Direct-to-Consumer Channels

Itamar Medical Ltd., a company that develops, manufactures, and markets non-invasive ambulatory diagnostic medical devices for sleep apnea and offers Total Sleep Solution using a cloud-based digital health platform, and SoClean Inc., a company that develops, manufactures, and markets sleep equipment sanitizers through direct-to-consumer (DTC) channels to the sleep apnea market, announced a collaboration agreement between their respective wholly-owned subsidiaries to make Itamar Medical’s WatchPAT ONE home sleep apnea test and Digital Health Services available to consumers. The collaboration is designed to overcome the barriers to sleep apnea testing and therapy solutions by enabling consumers to purchase remote sleep consultations and home-based sleep test using the WatchPAT ONE in the comfort of their own homes.

WatchPAT ONE is the first and only disposable home sleep apnea test (HSAT) cleared by the FDA. WatchPAT ONE provides an automated and comprehensive sleep report for interpretation and is simple to use with logistical advantages that are uniquely suited to the DTC market.

Under the terms of the collaboration agreement, SoClean’s Subsidiary ("SoClean") will have exclusivity to market and sell the WatchPAT ONE to the DTC Segment in the United States, subject to purchasing certain minimum quantities. SoClean will have exclusive DTC rights in the U.S. through any and all marketing and sales channels, excluding healthcare providers and facilities and SoClean parent company has agreed to guarantee the performance of the collaboration by its subsidiary.  SoClean plans to announce further details regarding its home sleep apnea testing service in Q1 2020.

About Itamar Medical Ltd.

Itamar Medical is engaged in research, development, sales and marketing of non-invasive medical devices for the diagnosis of respiratory sleep disorders and uses a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the cardiology market. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare costs. Its flagship PAT®-based product, the WatchPAT™ device, is a home-use diagnostic device for sleep breathing disorders. Its digital health platform, including CloudPAT™ and SleePATH™, facilitates seamless and complete care pathway management in a complex environment. Itamar Medical also offers the EndoPAT™ system, an FDA-cleared device to test endothelial dysfunction and to evaluate the risk of heart disease and other cardiovascular diseases. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information, visit www.itamar-medical.com.

About SoClean

SoClean Inc. is the creator of the world's first automated sleep equipment cleaner and sanitizer, an innovative device that naturally sanitizes sleep equipment without the need for disassembly, water or harsh chemicals. It's the safer, healthier way to breathe cleaner and have a better sleep experience. For more information, visit https://www.soclean.com.